scispace - formally typeset
D

Douglas Hayden

Researcher at Harvard University

Publications -  82
Citations -  10988

Douglas Hayden is an academic researcher from Harvard University. The author has contributed to research in topics: Randomized controlled trial & ARDS. The author has an hindex of 40, co-authored 78 publications receiving 9696 citations.

Papers
More filters
Journal ArticleDOI

Comparison of two fluid-management strategies in acute lung injury.

TL;DR: A conservative strategy of fluid management using explicit protocols applied for seven days in 1000 patients with acute lung injury improved the chances of death at 60 days and the conservative strategy improved fluid balance during the first seven days.
Journal ArticleDOI

Coronary CT Angiography versus Standard Evaluation in Acute Chest Pain

TL;DR: In patients in the emergency department with symptoms suggestive of acute coronary syndromes, incorporating CCTA into a triage strategy improved the efficiency of clinical decision making, as compared with a standard evaluation in theEmergency department, but it resulted in an increase in downstream testing and radiation exposure with no decrease in the overall costs of care.
Journal ArticleDOI

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

TL;DR: Pamidronate prevents bone loss in the hip and lumbar spine in men receiving treatment for prostate cancer with a gonadotropin-releasing hormone agonist.
Journal ArticleDOI

Comparison of the Spo2/Fio2 Ratio and the Pao2/Fio2 Ratio in Patients With Acute Lung Injury or ARDS

TL;DR: It is hypothesized that the pulse oximetric saturation (Spo(2))/Fio(2) (S/F) ratio can be substituted for the P/F ratio in assessing the oxygenation criterion of ALI and ARDS.
Journal ArticleDOI

Tidal Volume Reduction in Patients with Acute Lung Injury When Plateau Pressures Are Not High

TL;DR: Data from animal models with and without preexisting lung injury, studies of normal human respiratory system mechanics, and the results of five clinical trials of lung-protective mechanical ventilation strategies do not support the commonly held view that inspiratory plateau pressures of 30 to 35 cm H2O are safe.